Next‐Generation HER‐2 Tumor‐Targeted Delivery of the STING Agonist Immune‐Stimulating Antibody Conjugate (ISAC) Improves Anticancer Efficacy and Induces Immunological Memory
ABSTRACT Recently, rapidly evolving STING‐based immunotherapies have offered novel therapeutic options for various cancer types. However, systemic administration of STING agonists raises safety concerns, and intratumoral injection is constrained by tumor accessibility. Herein we developed an immune‐...
Salvato in:
| Autori principali: | , , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wiley
2025-07-01
|
| Serie: | MedComm |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1002/mco2.70254 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|